Trial | NCT00825396  Report issue

Title

An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension
A Pilot, Open-Label, Controlled Clinical Trial of C-KAD Ophthalmic Solution in Reducing Intraocular Pressure in Patients With Ocular Hypertension

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    12
The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.
Study Started
Apr 30
2007
Primary Completion
Apr 30
2009
Study Completion
Apr 30
2009
Last Update
Jun 11
2009
Estimate

Drug C-KAD Ophthalmic Solution

4 drops applied daily for 150 days

C-KAD Ophthalmic Solution Experimental

Criteria 

Inclusion Criteria:

Both eyes having intraocular pressure in the range of 22-30 mmHg at baseline
Both eyes having best corrected visual acuity better than 20/50

Exclusion Criteria:

Advanced glaucoma
Closed or barely open anterior chamber or history of angle closure
No Results Posted